Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/acetaminophen vs oxycodone sustained-release for moderate cancer pain
ChiCTR2400090048Phase 4Recruiting
- Sponsor
- Xiangyang No.1 People's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cancer pain comparing Oxycodone/acetaminophen tablets with Oxycodone hydrochloride sustained-release tablets (2 arms). Primary endpoint: Titration success rate. Started Sep 2024; status: recruiting.
02
Drugs
oxycodoneacetaminophen
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR2400090048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090048.